Newsfeeds - Spark Newswire

2 minute read

FDA
News

GigaGen Doses First Patient in Phase 1 Trial Of Recombinant Hyperimmune Polyclonal Antibody GIGA-2050 For COVID-19

Today, 10:28 AM

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, and a subsidiary of Grifols, announced today the first

GRFS

5 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 10:28 AM

On Wednesday morning, 67 companies achieved new lows for the year.

ACET

5 minute read

The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

By Shanthi Rexaline

Today, 10:28 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10)

ACAD

22 minute read

Earnings Scheduled For July 29, 2021

By Benzinga Insights

Today, 10:28 AM

Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.

1 minute read

Watching Grifols Shares Following Sam.gov Contract Opportunity Listing For Co.’s ‘2021 Vaccines For Adults (VFA)’ Via CDC

By Benzinga Newsdesk

Today, 10:28 AM

https://sam.gov/opp/3636bb2092884c4c8455c372887f1e14/view

GRFS

2 minute read

Grifols Announced Strategic Investment from GIC of $1B

By Charles Gross

Today, 10:28 AM

Grifols (NASDAQ: GRFS) and GIC, the sovereign wealth fund of Singapore, have entered into a definitive agreement under which GIC will invest ~USD 1 billion in Grifols' wholly owned US subsidiary Biomat USA.

GRFS

Latest news

GigaGen Doses First Patient in Phase 1 Trial Of Recombinant Hyperimmune Polyclonal Antibody GIGA-2050 For COVID-19

Stocks That Hit 52-Week Lows On Wednesday

The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

Earnings Scheduled For July 29, 2021

Watching Grifols Shares Following Sam.gov Contract Opportunity Listing For Co.’s ‘2021 Vaccines For Adults (VFA)’ Via CDC

Grifols Announced Strategic Investment from GIC of $1B